Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors

NAActive, not recruitingINTERVENTIONAL
Enrollment

363

Participants

Timeline

Start Date

May 23, 2019

Primary Completion Date

May 18, 2024

Study Completion Date

May 31, 2027

Conditions
Ovarian CancerEndometrial Cancer
Interventions
OTHER

Blood sample

"Two blood samples (2 tubes of 4 ml for each blood sample) will be collected per patient during the study period for EC and OC. One blood sample will be collected for control population. The first sample will be collected prior to any treatment for EC, OC, and control population.~For EC, the second collection will be done one month post-surgery. For OC, the second collection will be done 6 to 9 months after the initial diagnosis, in most cases at the completion of adjuvant chemotherapy. For control population, there will be no second sample."

Trial Locations (1)

75013

Service de chirurgie et oncologie gynécologique et mammaire, Paris

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03776630 - Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors | Biotech Hunter | Biotech Hunter